-
Strategies to determine treatment of acute coronary syndromes need to take gender into account.
-
There are no disease-modifying pharmacotherapies for COPD. That is, although bronchodilators, anticholinergic agents, and inhaled corticosteroids improve FEV1 and reduce symptoms, decline in pulmonary function continues unabated and lung function returns promptly to pretreatment status once medication is stopped.
-
Using blood pressure, BUN, serum sodium, and presence of peripheral arterial disease as predictors of mortality in heart failure patients, 67% who had 3 or more factors died within 6 months and would qualify for the Medicare hospice benefit.
-
A randomized controlled trial in the Netherlands showed that oral prednisolone and naproxen were equivalent in the treatment of acute gout with no difference in side effects.
-
-
Optimizing medical and lifestyle change therapy rather than performing PCI is appropriate as the initial management strategy for most patients with known CAD who do not have unstable or disabling symptoms.
-
-
In This Issue: Guidelines for prediabetes from The American College of Endocrinology; statins for the prevention of dementia? Possible help for women suffering from sexual side effects while on antidepressants; government incentives for electronic prescribing; FDA Actions.
-
As kids prepare for school this fall, remember that the United States American College of Immunization Practices (ACIP) recommends administration of meningococcal vaccine to previously unvaccinated children starting high school or going off to college.
-
In March 2004, an infectious disease specialist in New York queried the Emerging Infections Network (EIN) listserv about treatment of a patient with M. abscessus wound infection following abdominoplasty in the Dominican Republic.